Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Upst Bullish Signal Emerges On Volume Spike 20260403 1 What Chart Pattern Is Kronos Worldwide Kro Stock Forming Kro Q4 Earnings Misses Estimates By 0.47 20260409 1 Is Luxexperience Luxe Stock Good For Beginners Price At 7.83 Up 0.58 20260406 Will Pebblebrook Peb Stock Miss Expectations Price At 12.71 Down 0.70 20260406 FTV beats earnings estimates by 8 but Fortive Corporation shares fall on cautious outlook modest revenue growth What Bridgeline BLIN is doing to protect its market share Hovering 20260508 What Aeva AEVA is doing that creates lasting advantage Q1 2026 EPS Tops Views Market Pulse Technology leads broad gains as consumer sector trails peers Is Fortress FBIOP stock trading at a premium valuation Weakens 20260420 DAAQU DigitalAsset quarterly earnings report shows no revenue data as investors await acquisition pipeline update and strategic milestones Owlet OWLT Stock Discount or Premium Check Q4 2025 Earnings Beat Estimates Is CohenSteers CNS stock weak today Cohen and Steers posts 34 EPS miss vs analyst estimates Is Stryker Corporation SYK stock influenced by uncertainty Stryker Corporation posts 3 EPS miss vs consensus HYPR Hyperfine reports narrower than expected Q4 2025 loss yet shares drop 42 percent in todays session How CRH PLC CRH is navigating logistics challenges CRH PLC posts 118 EPS beat narrower than expected loss MFG Mizuho delivers 193 percent Q1 2026 EPS beat yet shares dip 036 percent in todays trading Where does Adeia ADEA stock rank in its sector Adeia delivers 296 EPS beat topping analyst estimates Talkspace TALK Q1 2026 Results Miss Estimates EPS 004 vs 002 BNY Muni Fund DSM Declines 098 Amid Market Weakness 20260515 White WTM Stock Analysis 103 Gain What to Watch 20260515 Cerebras IPO Soars Nvidias AI Chip Competitor Makes Stunning Market Debut What Annexon ANNXs 261 Decline Means for Investors 20260515 Atrium Therapeutics RNA Slides 212 as Selling Pressure Mounts 20260518 Perimeter PMTR Stalls at 1039 Consolidation Phase 20260518 Royal RCL Crushes Q1 2026 Estimates EPS 360 Tops Views Marine MPX Q1 2026 Earnings Revenue NA Matching Views Special Edition Trump Passport Sparks Political Controversy Potential Legal Challenges Ahead Bridger Aero BAERW Gains 1309 Support Holds at 029 20260520 BofA BAC Q1 2026 Earnings 111 EPS Surges Past 102 Estimates Birkenstock Stock Surges on 250 Million Share Buyback Announcement Silicon Valley Turns to Boring Businesses AI and Dealmaking Reshape Unsexy Industries Federal Reserve Faces Challenges in Justifying Rate Cuts as Cost of Living Pressures Intensify Wall Street Ends Mixed Oil Prices Slide on Iran Deal Hopes Micron Gains 56 GlobalFoundries Drops 9 SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags Rigetti Computing Surges 48 on 100 Million Government Backing Announcement RWAY Q1 2026 Earnings EPS Falls Short of Analyst Expectations Petco WOOF Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 6 Toast Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher OPCH Q1 2026 Earnings EPS Beat Amid Caution Stock Slips 191 SOWG Q3 2025 Earnings Significant EPS Miss Overshadows Quarter Zentek Ltd ZTEK Declines 782 as Stock Tests Key Support Level Alico Inc Holds Steady Near 4085 as Market Consolidates Shopify SHOP Advances 184 as Bullish Momentum Builds Toward Key Resistance FirstSun Capital Bancorp FSUN Shows Modest Decline Trading Near Midpoint of Key Range Beneficient BENF Stock Is It Forming a Reversal Weakens 20260420 TNET TriNet Group reports Q4 2025 EPS ahead of analyst forecasts shares gain roughly three percent San Juan SJT Stock Swing Trade Technical Weakness 20260420 What makes Calamos Fund CHY a stronger buy than it appears Momentum Building 20260511 DOUG Doug Elliman rises 374 percent as Q4 2025 revenue growth offsets steep earnings miss Is Tvardi Therapeutics TVRD stock moving unpredictably Tvardi Therapeutics posts 183 downside EPS miss amid clinical trial costs